彥臣生技藥品股份有限公司 Approved
最後更新時間 2025/07/10 , 06:04 PM
最後更新時間 2025/07/10 , 06:04 PM
負責人
Huang,Zhong-Yang
統一編號
12676817
成立日期
2000/12/29
資本額
NT$800,000,000
實收資本額
NT$493,765,000
股票代號
4732
電話
02-25706300
地址
6F, No. 36, Sec. 3, Bade Rd., Songshan Dist., Taipei City, 105, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Huang,Zhong-Yang Chairman 6.86%
Wu,Wan-De Vice Chairman 2.15%
Lin,Jun-Yao Director 5.32%
Xu,Feng-Lin Director 0.00%
Su,Qing-Yang Director 0.15%
CHAICO INVESTMENT CORPORATION Director 5.94%
Wang,Cai-Wang Independent Director 0.00%
Li,An-Rong Independent Director 0.00%
Liang,Bo-Song Independent Director 0.00%
營業項目
  • Wholesale of Other Food(454920)
  • Wholesale of Pharmaceutical and Medical Goods(457111)
  • 公司歷程
  • Change Capital to 800,000,000
    2019/06/27
  • Change Capital to 600,000,000
    2014/12/12
  • Change Person in Charge to Huang,Zhong-Yang
    2013/12/19
  • Change Person in Charge to
    2013/11/13
  • Change Person in Charge to Hong,Ming-Ru
    2012/11/09
  • Change Person in Charge to Wang,Liang-Shun
    2012/04/09
  • Change Person in Charge to Hong,Ming-Ru
    2012/02/06
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 130,795 160,142 228,590
    Operating cost 58,772 72,763 98,663
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 72,023 87,379 129,927
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 72,023 87,379 129,927
    Operating expenses 66,634 83,945 103,580
    Other gain (loss), net - - -
    Operating profit (loss) 5,389 3,434 26,347
    Non-operating income and expenses 4,397 6,490 3,677
    Net profit (loss) before tax 9,786 9,924 30,024
    Income tax expense (benefits) 2,498 -196 0
    Net profit (loss) of ongoing business for the current period 7,288 10,120 30,024
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 7,288 10,120 30,024
    Other comprehensive profit (loss), net 264 -250 218
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 7,552 9,870 30,242
    Net profit (loss) attributable to owners of parent company 9,031 10,120 30,024
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests -1,743 - -
    Comprehensive profit (loss) attributable to owners of parent company 9,302 9,870 30,242
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests -1,750 - -
    Basic earnings per share (yuan) 0 0 0
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities 14,845 62,202 13,853
    Net cash inflows (outflows) from investing activities -6,724 -19,716 -51,931
    Net cash inflow (outflow) from financing activities 5,238 -28,658 -18,726
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 263 -249 217
    Increase (decrease) in cash and cash equivalents in the current period 13,622 13,579 -56,587
    Beginning balance of cash and cash equivalents 112,552 98,973 155,560
    Ending balance of cash and cash equivalents 126,174 112,552 98,973
    項目 2024 2023 2022
    Current asset 630,162 627,006 622,261
    Non-current asset 70,750 71,445 70,339
    Total asset 700,912 698,451 692,600
    Current liability 50,575 54,289 42,846
    Non-current liability 8,406 10,598 8,242
    Total liability 58,981 64,887 51,088
    share capital 492,900 492,900 492,900
    Equity - secruity token - - -
    capital reserve 82,776 77,668 70,841
    retained earning 63,459 64,286 78,811
    Other equity -1,019 -1,290 -1,040
    Treasury stock - - -
    Total equity attributable to owners of parent company 638,116 633,564 641,512
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 3,815 - -
    Total Equity 641,931 633,564 641,512
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 12 12 13
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 御婦寶
  • 蜂の康
  • LiBD
  • 昂首樂
  • PPLS INSIDE
  • PPLs
  • NBM
  • NBF
  • 慧祐全
  • 蜂力沛
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Petition for trial
    2020
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。